STOCK BASED COMPENSATION (Details Narrative) - USD ($)								3 Months Ended						9 Months Ended
	Sep. 21, 2022	Sep. 09, 2022	Jun. 15, 2022	Mar. 28, 2022	Mar. 25, 2022	Mar. 23, 2022	Jan. 12, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Compensation costs								$ 1,600,000			$ 735,000			$ 3,900,000	$ 2,300,000
Number of restricted stock award, value								0	$ 0	$ 0			$ 0
Common stock issued through stock options								$ 982,000	$ 2,220,000	$ 993,000	$ 993,000	$ 4,723,000	$ 2,588,000
Options outstanding								3,500,000						3,500,000
Aggregate intrinsic value								$ 8,300,000						$ 8,300,000
Number of shares available for grant								1,700,000						1,700,000
Five Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock award							25,000
Number of restricted stock award, value							$ 613,000
Grants vest term							5 years
Nine Members of Board of Directors [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of common stock award	6,453		3,933			5,598	5,508
Fair value of grant options	$ 113,000		$ 68,000			$ 135,000	$ 135,000
Two Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of restricted stock award					78,000
Number of restricted stock award, value					$ 1,900,000
Grants vest term					5 years
Forty-Five Participants [Member] | Stock Options [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Grants vest term				5 years
Fair value of grant options				$ 2,100,000
Option to purchase common stock				470,800
One Participants [Member] | Stock Options [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Fair value of grant options		$ 433,000
Option to purchase common stock		100,000
Fourteen Participants [Member] | Stock Options [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Common stock issued through stock options, shares														404,160
Weighted-average exercise price														$ 10.38
Common stock issued through stock options														$ 4,200,000
Aggregate intrinsic value of options exercised														$ 4,000,000.0